Press
The Bavarian Cancer Research Center (BZKF) provides press releases for editorial reporting, which may be used free of charge. In any case, it is obligatory to indicate the source. Ideally, send us a link to the online report or a specimen copy after publication.
Press releases:
Pressemitteilung Ein Jahr – BürgerTelefonKrebs (09.2021)
Pressemitteilung Netzwerktreffen (07.2021)
Pressemitteilung ECTU (05.2021)
Pressemitteilung zum Weltgesundheitstag (03.2021)
Pressemitteilung zum Weltkrebstag (01.2021)
Pressemitteilung BürgerTelefonKrebs (10.2020)
Further information and insights into our work:
BZKF Annual Report 2022
BZKF Brief brochure 2022
BZKF Imagebroschüre 2021 (German)
Logo and image files:
BZKF-Logo_CMYK.tif
BZKF-Logo_RGB.jpg
BZKF-Logo_RGB.pdf
Thank you for your interest in the BZKF. If you are a journalist and have questions, need further information or picture material, are looking for an expert for research or an interview, please do not hesitate to contact us.
Updates:
BZKF Annual Report 2022
In this annual report, you will get an insight into the developments of the BZKF in the third year of funding by the Bavarian State Ministry of Science and the Arts.
Uniform contract template and central BZKF coordinating body for clinical oncology studies adopted
The aim is to accelerate the conclusion of a contract for the performance of clinical trials and thus increase competitiveness.
Disease network-based artificial intelligence elucidates factors in melanoma prognosis
Multiple types of genomic aberrations occur in cutaneous melanoma, and some can impact the prognosis of the disease.
Segment 2/3 partial liver transplantation with 2-stage liver resection for the treatment of non-resectable liver metastases from colorectal cancer – RAPID MUC study
Background: The most important pillar of a curative treatment of colorectal liver metastases is surgical liver resection. If the complete removal of...
look good feel better – Cosmetic seminars for cancer patients
The diagnosis of cancer, which is given annually to more than 230,000 women in Germany, means not only the struggle with survival, but also a daily...
POSITIVE RESULTS OF THE GENTHERAPIE CRISPR/CAS9 ALSO AT PATIENTS WITH SICHELZELL ERKRANKUNG
At the end of 2019, the first successes in the treatment of beta-thalassemia patients with the CRISPR/Cas9 procedure at the University Hospital...
Oncological Nursing Congress Würzburg 2020 !!! NEW TERMIN !!!
The care, care and support of patients and their relatives in the oncological, pain therapy and palliative care sector places high demands on nurses...
Molecular Diagnostics and Therapy Program
In order to meet the growing importance of precision oncological diagnostics and therapy, a "Molecular TumorBoard – MTB" was established at the CCC...
Rowing course for cancer patients
The CCC Erlangen-EMN offers those affected an exceptional range of sports with professional trainers of the rowing club Erlangen e. V. Patients with...
Center for Oligometastatic Cancers
The ICCA at the University Hospital Augsburg has a special interdisciplinary special team for cancer patients whose tumours have already spread, but...
Liquid Biopsy as a tool for diagnosing and controlling therapy for solid tumors – NeoRect study
Supporting personalised (patient-related "tailor-made") therapy decisions based on the patient-specific molecular profile of tumors is an important...
Interdisciplinary Study Center Clinical Oncology
In 2020, the Department of Hematology & Internal Oncology and the Clinic for Children & Adolescents established a joint interdisciplinary...